Extended Data Fig. 3: Pretreatment single marker immunohistochemistry compared to posttreatment cell density and TLS density. | Nature Immunology

Extended Data Fig. 3: Pretreatment single marker immunohistochemistry compared to posttreatment cell density and TLS density.

From: Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Extended Data Fig. 3

a, Line plots showing density of CD3, CD8, CD20, CD56 positive cells, and percent area of tissue positive for CXCL13 in pretreatment biopsy and post-neoadjuvant ICB HCC tumors. b, Dotplots showing correlation between post-treatment TLS density and pretreatment density of CD3, CD8, CD20, CD56 positive cells, and percent area of tissue positive for CXCL13 tissue. Statistical significance was determined by two-tailed t-test (a) and Pearson’s correlation (b).

Back to article page